$GDRX
GoodRx Holdings, Inc.

2019 Q4 Form 10-K Financial Statement

#000156459021012614 Filed on March 12, 2021

View on sec.gov

Income Statement

Concept 2019 Q4 2018 Q4 2018
Revenue $113.3M $249.5M
YoY Change 58.73%
Cost Of Revenue $4.600M $6.000M
YoY Change 93.55%
Gross Profit $108.7M $243.5M
YoY Change 57.91%
Gross Profit Margin 95.94% 97.59%
Selling, General & Admin $58.90M $112.5M
YoY Change 35.1%
% of Gross Profit 54.19% 46.22%
Research & Development $9.800M $43.89M
YoY Change 281.69%
% of Gross Profit 9.02% 18.03%
Depreciation & Amortization $7.900M $300.0K
YoY Change -96.7%
% of Gross Profit 7.27% 0.12%
Operating Expenses $72.90M $156.4M
YoY Change 50.7%
Operating Profit $35.80M $77.25M
YoY Change 53.28%
Interest Expense -$10.00M -$22.00M
YoY Change 218.84%
% of Operating Profit -27.93% -28.48%
Other Income/Expense, Net -$3.000M -$24.90M
YoY Change
Pretax Income $17.90M $52.35M
YoY Change 31.86%
Income Tax $2.700M $8.555M
% Of Pretax Income 15.08% 16.34%
Net Earnings $15.20M $43.79M
YoY Change 52.06%
Net Earnings / Revenue 13.42% 17.55%
Basic Earnings Per Share $0.12
Diluted Earnings Per Share $39.67K $0.12
COMMON SHARES
Basic Shares Outstanding 111.8M
Diluted Shares Outstanding 118.3M

Balance Sheet

Concept 2019 Q4 2018 Q4 2018
SHORT-TERM ASSETS
Cash & Short-Term Investments $34.60M
YoY Change
Cash & Equivalents $26.05M $34.60M
Short-Term Investments
Other Short-Term Assets $3.400M
YoY Change
Inventory
Prepaid Expenses $5.014M
Receivables $48.13M $33.40M
Other Receivables $1.600M
Total Short-Term Assets $86.58M $73.10M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $1.860M $1.000M
YoY Change
Goodwill $236.2M $220.4M
YoY Change 7.17%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.162M $2.000M
YoY Change
Total Long-Term Assets $300.2M $241.7M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $86.58M $73.10M
Total Long-Term Assets $300.2M $241.7M
Total Assets $386.8M $314.8M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.851M $7.200M
YoY Change
Accrued Expenses $3.700M
YoY Change
Deferred Revenue $3.453M
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $7.029M $5.400M
YoY Change
Total Short-Term Liabilities $33.37M $16.60M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $663.9M $716.8M
YoY Change
Other Long-Term Liabilities $2.974M $3.300M
YoY Change
Total Long-Term Liabilities $666.9M $720.1M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $33.37M $16.60M
Total Long-Term Liabilities $666.9M $720.1M
Total Liabilities $737.4M $740.2M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$1.097B
YoY Change
Common Stock $8.788M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.088B -$1.162B -$425.4M
YoY Change
Total Liabilities & Shareholders Equity $386.8M $314.8M
YoY Change

Cashflow Statement

Concept 2019 Q4 2018 Q4 2018
OPERATING ACTIVITIES
Net Income $15.20M $43.79M
YoY Change 52.06%
Depreciation, Depletion And Amortization $7.900M $300.0K
YoY Change -96.7%
Cash From Operating Activities $33.00M $45.25M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures -$3.000M $804.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$18.70M $0.00
YoY Change
Cash From Investing Activities -$21.80M -$3.458M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid $1.346B
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $294.9M
YoY Change
Cash From Financing Activities -48.00M -24.73M
YoY Change
NET CHANGE
Cash From Operating Activities 33.00M 45.25M
Cash From Investing Activities -21.80M -3.458M
Cash From Financing Activities -48.00M -24.73M
Net Change In Cash -36.80M 17.06M
YoY Change
FREE CASH FLOW
Cash From Operating Activities $33.00M $45.25M
Capital Expenditures -$3.000M $804.0K
Free Cash Flow $36.00M $44.45M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2020 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2020 dei Entity Small Business
EntitySmallBusiness
false
CY2020 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020 dei Entity File Number
EntityFileNumber
001-39549
CY2020 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-5104396
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020 dei Entity Address Address Line1
EntityAddressAddressLine1
2701 Olympic
CY2020 dei Entity Address Address Line2
EntityAddressAddressLine2
Boulevard
CY2020 dei Entity Address City Or Town
EntityAddressCityOrTown
Santa Monica
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90404
CY2020 dei City Area Code
CityAreaCode
855
CY2020 dei Local Phone Number
LocalPhoneNumber
268-2822
CY2020 dei Trading Symbol
TradingSymbol
GDRX
CY2020 dei Security12b Title
Security12bTitle
Class A Common Stock, $0.0001 par value
CY2020 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q2 dei Entity Public Float
EntityPublicFloat
0
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
968691000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26050000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
2900000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
68729000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
48129000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
46048000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
12403000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1086368000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
86582000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23057000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1860000
CY2020Q4 us-gaap Goodwill
Goodwill
261116000
CY2019Q4 us-gaap Goodwill
Goodwill
236225000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
36919000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
21267000
CY2020Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
19800000
CY2019Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
5178000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27712000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
32315000
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
13117000
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2207000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2025000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1162000
CY2020Q4 us-gaap Assets
Assets
1470114000
CY2019Q4 us-gaap Assets
Assets
386796000
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0001809519
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Entity Registrant Name
EntityRegistrantName
GoodRx Holdings, Inc.
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
29587000
CY2019 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
14016000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
61816000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10291000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7851000
CY2020Q4 gdrx Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
37692000
CY2019Q4 gdrx Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
15556000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7029000
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7029000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4539000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2937000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
59551000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
33373000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
659888000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
663893000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
33467000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
37129000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5849000
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2974000
CY2020Q4 us-gaap Liabilities
Liabilities
758755000
CY2019Q4 us-gaap Liabilities
Liabilities
737369000
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
737009000
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2101773000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
8788000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1390453000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1096830000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
711359000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-1087582000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1470114000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
386796000
CY2020Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.006
CY2019Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.006
CY2020Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
0
CY2019Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
130000000
CY2020Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0
CY2019Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
126046000
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2019Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
126046000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
550700000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
388224000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
249522000
CY2018 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
6035000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29300000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43894000
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
255135000
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
176967000
CY2018 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
104177000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
461451000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14692000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8359000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
18430000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
13573000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9806000
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
826419000
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
248548000
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
172271000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-275719000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
139676000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
77251000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
22000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2967000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7000
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4877000
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-2857000
CY2020 us-gaap Interest Income Other
InterestIncomeOther
160000
CY2019 us-gaap Interest Income Other
InterestIncomeOther
715000
CY2018 us-gaap Interest Income Other
InterestIncomeOther
154000
CY2020 us-gaap Interest Expense Debt
InterestExpenseDebt
27913000
CY2019 us-gaap Interest Expense Debt
InterestExpenseDebt
49569000
CY2018 us-gaap Interest Expense Debt
InterestExpenseDebt
22193000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-27731000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-56698000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-24903000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-303450000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
82978000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
52348000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-9827000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16930000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8555000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-293623000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
66048000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
43793000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-293623000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
42441000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
13795000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-293623000
CY2019 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
42745000
CY2018 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
14226000
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.07
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2018 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.07
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2018 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
274696000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
226607000
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
111842000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
274696000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
231209000
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
118344000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-31753000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3349000
CY2018 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
166777000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1762000
CY2018 us-gaap Dividends
Dividends
1346355000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-1162427000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3042000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1623000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4132000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10831000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
399722000
CY2020 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
83575000
CY2020 gdrx Stock Issued During Period Value Charitable Stock Donation
StockIssuedDuringPeriodValueCharitableStockDonation
41721000
CY2020 us-gaap Profit Loss
ProfitLoss
-293623000
CY2019 us-gaap Profit Loss
ProfitLoss
66048000
CY2018 us-gaap Profit Loss
ProfitLoss
43793000
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3390000
CY2019 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3381000
CY2018 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1239000
CY2020 gdrx Non Cash Operating Lease Expense
NonCashOperatingLeaseExpense
4478000
CY2019 gdrx Non Cash Operating Lease Expense
NonCashOperatingLeaseExpense
2150000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
397285000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
3747000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
1762000
CY2020 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2068000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-10910000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-5674000
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2433000
CY2020 gdrx Loss On Abandonment And Impairment Of Operating Lease Assets
LossOnAbandonmentAndImpairmentOfOperatingLeaseAssets
961000
CY2020 gdrx Charitable Stock Donation
CharitableStockDonation
41721000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16139000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14517000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12843000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
40935000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-102000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2627000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2154000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
515000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
665000
CY2020 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
15010000
CY2019 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
11225000
CY2018 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
77000
CY2020 gdrx Increase Decrease Operating Lease Liabilities
IncreaseDecreaseOperatingLeaseLiabilities
4576000
CY2019 gdrx Increase Decrease Operating Lease Liabilities
IncreaseDecreaseOperatingLeaseLiabilities
-2309000
CY2020 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2875000
CY2019 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
168000
CY2018 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2957000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
131341000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
83286000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
45253000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20553000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1425000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
804000
CY2020 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
55793000
CY2019 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
31306000
CY2020 us-gaap Payments For Software
PaymentsForSoftware
15271000
CY2019 us-gaap Payments For Software
PaymentsForSoftware
4324000
CY2018 us-gaap Payments For Software
PaymentsForSoftware
2654000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-91617000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3458000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-37055000
CY2020 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
891793000
CY2020 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
100000000
CY2020 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
28000000
CY2019 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
154613000
CY2018 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
901813000
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
35029000
CY2019 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
211845000
CY2018 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
294937000
CY2020 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1306000
CY2019 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2214000
CY2018 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
25613000
CY2018 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
737009000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1623000
CY2018 us-gaap Payments Of Dividends
PaymentsOfDividends
1346355000
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
4937000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5343000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3042000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3349000
CY2020 gdrx Proceeds From Early Exercise Of Stock Options
ProceedsFromEarlyExerciseOfStockOptions
667000
CY2020 gdrx Employee Taxes Paid Related To Net Share Settlement Of Equity Awards
EmployeeTaxesPaidRelatedToNetShareSettlementOfEquityAwards
78714000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
905817000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-54781000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-24734000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
945541000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8550000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
17061000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26050000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
34600000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
17539000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
971591000
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
29228000
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
19400000
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
11700000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
24517000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
48443000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
18658000
CY2020 gdrx Noncash Purchase Of Property And Equipment Included In Accounts Payable And Accrued Expenses And Other Current Liabilities
NoncashPurchaseOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpensesAndOtherCurrentLiabilities
2100000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
234000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
29493000
CY2020 gdrx Noncash Stock Based Compensation Included In Capitalized Software
NoncashStockBasedCompensationIncludedInCapitalizedSoftware
2437000
CY2019 gdrx Noncash Stock Based Compensation Included In Capitalized Software
NoncashStockBasedCompensationIncludedInCapitalizedSoftware
385000
CY2020 gdrx Noncash Capitalized Software Development Costs In Accrued Expenses And Other
NoncashCapitalizedSoftwareDevelopmentCostsInAccruedExpensesAndOther
1273000
CY2020 gdrx Conversion Of Preferred Stock To Common Stock
ConversionOfPreferredStockToCommonStock
737009000
CY2018 gdrx Conversion Of Preferred Stock To Common Stock
ConversionOfPreferredStockToCommonStock
166777000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34600000
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements, including the accompanying notes. The Company bases its estimates on historical factors, current circumstances, and the experience and judgment of management. The Company evaluates its estimates and assumptions on an ongoing basis. Actual results could differ from those estimates. Significant estimates reflected in the consolidated financial statements include revenue recognition, valuation of intangible assets, and assumptions used for purpose of determining stock-based compensation.</p>
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Arial;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Certain Risks and Concentrations </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist principally of cash, cash equivalents and accounts receivable. The Company maintains cash deposits with multiple financial institutions in the United States which, at times, may exceed federally insured limits. Cash may be withdrawn or redeemed on demand. The Company believes that the financial institutions that hold its cash are financially sound and, accordingly, minimal credit risk exists with respect to these balances. The Company has not experienced any losses in such accounts.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company extends credit to its customers based on an evaluation of their ability to pay amounts due under contractual arrangements and generally does not obtain or require collateral.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the year ended December 31, 2020, three customers accounted for approximately 17%, 14% and 11% of the Company&#8217;s revenue. At December 31, 2020, one customer accounted for 12%<font style="font-family:Times New Roman;color:#000000;">&#160;</font>of the Company&#8217;s accounts receivable balance. For the year ended December 31, 2019, two customers accounted for approximately 24% and 23% of the Company&#8217;s revenue. At December 31, 2019, two customers accounted for 17% and 16% of the Company&#8217;s accounts receivable balance. For the year ended December 31, 2018, three customers accounted for approximately 27%, 19%, and 15% of the Company&#8217;s revenue. <font style="color:#808080;font-family:Times New Roman;"> </font> <font style="color:#808080;font-family:Times New Roman;"> </font>&nbsp;&nbsp;<font style="color:#808080;font-family:Times New Roman;"> </font> </p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2020, the World Health Organization declared the outbreak of the novel coronavirus disease (&#8220;COVID&#8211;19&#8221;) a pandemic. The Company&#8217;s prescription offering initially experienced a decline in activity as many consumers avoided visiting healthcare professionals and pharmacies in-person, though beginning in the second half of 2020 activity in the Company&#8217;s prescription offering improved. In addition, the Company has experienced a significant increase in demand for the telehealth offerings. The Company only commenced its telehealth offerings following the acquisition of HeyDoctor (now rebranded to GoodRx Care) in April 2019. The full extent to which the outbreak of COVID-19 will impact the Company&#8217;s business, results of operations and financial condition is still unknown and will depend on future developments, which are highly uncertain and cannot be predicted, including, but not limited to, the duration and spread of the outbreak, its severity, the actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating conditions can resume.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In light of the currently unknown ultimate duration and severity of COVID-19, the Company faces a greater degree of uncertainty than normal in making certain judgments and estimates needed to apply significant accounting policies. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts COVID-19 as of December 31, 2020 and through the date of this report. The accounting matters assessed included, but were not limited to, the Company&#8217;s allowance for doubtful accounts, the carrying value of the goodwill and other long-lived assets, incentive-based compensation and income taxes.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of the date of these consolidated financial statements, management is not aware of any specific event or circumstance that would require an update to estimates or judgments or a revision to the carrying value of assets or liabilities. However, these estimates and judgments may change as new events occur and additional information is obtained, which may result in changes being recognized in the Company&#8217;s consolidated financial statements in future periods.</p>
CY2019 gdrx Variable Interest Entitys Percentage Of Total Assets And Liabilities
VariableInterestEntitysPercentageOfTotalAssetsAndLiabilities
0.01
CY2020 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2020 us-gaap Property Plant And Equipment Depreciation Methods
PropertyPlantAndEquipmentDepreciationMethods
Depreciation is computed using the straight-line method over the estimated useful lives of the assets
CY2020 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2019 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2019 us-gaap Advertising Expense
AdvertisingExpense
163700000
CY2018 us-gaap Advertising Expense
AdvertisingExpense
89300000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
0
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
0
CY2020Q4 us-gaap Change In Accounting Principle Accounting Standards Update Adoption Date
ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
2020-01-01
CY2020Q4 us-gaap Change In Accounting Principle Accounting Standards Update Immaterial Effect
ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
true
CY2018 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2018 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
1000000
CY2019 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2018 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2020 us-gaap Advertising Expense
AdvertisingExpense
222400000
CY2020 gdrx Entity Incorporation Month And Year
EntityIncorporationMonthAndYear
2015-09
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020 gdrx Minimum Percentage Of Aggregate Outstanding Shares Of Common Stock To Be Cease
MinimumPercentageOfAggregateOutstandingSharesOfCommonStockToBeCease
0.10
CY2020 us-gaap Common Stock Conversion Features
CommonStockConversionFeatures
Each share of Class B Common Stock is convertible into one share of Class A Common Stock at any time at the option of the holder and will automatically convert to Class A Common Stock upon any transfer, except for certain permitted transfers. All Class B Common Stock will convert automatically into an equivalent number of Class A Common Stock upon the earlier of (i) September 25, 2027; and (ii) the first date the aggregate number of shares of Class B Common Stock cease to represent at least 10% of the aggregate outstanding shares of common stock.
CY2020 gdrx Variable Interest Entitys Percentage Of Total Assets And Liabilities
VariableInterestEntitysPercentageOfTotalAssetsAndLiabilities
0.01
CY2020Q4 us-gaap Change In Accounting Principle Accounting Standards Update Adopted
ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
true
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2130000
CY2020 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201813Member
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
28564000
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
17484000
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5014000
CY2019Q4 us-gaap Lease Incentive Receivable
LeaseIncentiveReceivable
7389000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
25187000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3127000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1267000
CY2020 us-gaap Depreciation
Depreciation
1400000
CY2019 us-gaap Depreciation
Depreciation
700000
CY2018 us-gaap Depreciation
Depreciation
300000
CY2020Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
21800000
CY2018Q4 us-gaap Goodwill
Goodwill
220420000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
90209000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
53290000
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
61898000
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
40631000
CY2020 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P8Y
CY2019 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P4Y4M24D
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
12700000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
11200000
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9100000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
7916000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
6240000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
4681000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2415000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2413000
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
13254000
CY2020Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
26344000
CY2019Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
7363000
CY2020Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
6544000
CY2019Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
2185000
CY2020 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
4400000
CY2019 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1700000
CY2018 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
400000
CY2020Q4 gdrx Capitalized Software Costs Not Ready For Intended Use
CapitalizedSoftwareCostsNotReadyForIntendedUse
5200000
CY2020Q4 gdrx Capitalized Computer Software Expected Amortization Year One
CapitalizedComputerSoftwareExpectedAmortizationYearOne
6622000
CY2020Q4 gdrx Capitalized Computer Software Expected Amortization Year Two
CapitalizedComputerSoftwareExpectedAmortizationYearTwo
5272000
CY2020Q4 gdrx Capitalized Computer Software Expected Amortization Year Three
CapitalizedComputerSoftwareExpectedAmortizationYearThree
2670000
CY2020Q4 gdrx Capitalized Computer Software Expected Amortization
CapitalizedComputerSoftwareExpectedAmortization
14564000
CY2020Q4 gdrx Accrued Bonus And Other Payroll Related Current
AccruedBonusAndOtherPayrollRelatedCurrent
13607000
CY2019Q4 gdrx Accrued Bonus And Other Payroll Related Current
AccruedBonusAndOtherPayrollRelatedCurrent
3037000
CY2020Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
10045000
CY2019Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
5820000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6852000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3453000
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1349000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7188000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1897000
CY2020 gdrx Noncancellable Operating Lease Expiry Year
NoncancellableOperatingLeaseExpiryYear
2031
CY2020Q4 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P10Y
CY2020 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
Certain of the Company’s facility leases contain renewal options for periods of up to 10 years, at the Company’s election.
CY2020 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
7000000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
3000000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
2500000
CY2020Q4 us-gaap Lease Incentive Receivable Current
LeaseIncentiveReceivableCurrent
5700000
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y2M12D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y10M24D
CY2019 us-gaap Operating Lease Expense
OperatingLeaseExpense
3000000
CY2018 us-gaap Operating Lease Expense
OperatingLeaseExpense
1900000
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0599
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4539000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5343000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4498000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4583000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
4760000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
27796000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
51519000
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
13513000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.032
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
38006000
CY2020Q4 us-gaap Lease Incentive Receivable
LeaseIncentiveReceivable
1600000
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
380000
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
806000
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
273000
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-51000
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.060
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
235000
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
20012000
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
10368000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
848000
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2592000
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
620000
CY2020 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
1083000
CY2019 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
22604000
CY2018 us-gaap Current Federal State And Local Tax Expense Benefit
CurrentFederalStateAndLocalTaxExpenseBenefit
10988000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-7472000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-4670000
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1789000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-3438000
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1004000
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-644000
CY2020 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-10910000
CY2019 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-5674000
CY2018 us-gaap Deferred Federal State And Local Tax Expense Benefit
DeferredFederalStateAndLocalTaxExpenseBenefit
-2433000
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-63725000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
17425000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
10993000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-2768000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
988000
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-154000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
609000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
313000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-99000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-19961000
CY2019 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-788000
CY2018 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-1276000
CY2020 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
3541000
CY2019 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
1661000
CY2018 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
858000
CY2020 gdrx Income Tax Reconciliation Nondeductible Officers Compensation
IncomeTaxReconciliationNondeductibleOfficersCompensation
79046000
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-293000
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.204
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.163
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2303000
CY2020Q4 us-gaap Deferred Tax Assets Deferred Gain On Sale Leaseback Transaction
DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction
8747000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
24476000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4422000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
4146000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
296000
CY2020Q4 us-gaap Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
8403000
CY2020Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
9329000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
215000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
37861000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
268000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
37593000
CY2020Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
825000
CY2020Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
6377000
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
4621000
CY2020Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Software
DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware
4557000
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
8096000
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
13117000
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3108000
CY2019Q4 us-gaap Deferred Tax Assets Deferred Gain On Sale Leaseback Transaction
DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction
9111000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
840000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
1845000
CY2019Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
2524000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
570000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
17998000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
561000
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
17437000
CY2019Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
214000
CY2019Q4 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
9002000
CY2019Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
335000
CY2019Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Software
DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware
1072000
CY2019Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
4607000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
15230000
CY2019Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
2207000
CY2020Q1 gdrx Interest Expense Deduction Percentage Of Adjusted Taxable Income Cares Act
InterestExpenseDeductionPercentageOfAdjustedTaxableIncomeCARESAct
0.30
CY2020Q1 gdrx Interest Expense Deduction Percentage Of Adjusted Taxable Income Cares Act
InterestExpenseDeductionPercentageOfAdjustedTaxableIncomeCARESAct
0.50
CY2020Q1 gdrx Adjustment To Deferred Tax Assets And Income Tax Payable Cares Act
AdjustmentToDeferredTaxAssetsAndIncomeTaxPayableCARESAct
2300000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
865000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
458000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
3186000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4509000
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
879000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
744000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4374000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
126000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
3327000
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
119000
CY2020 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
317000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
7391000
CY2020Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
6700000
CY2020Q4 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
500000
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
200000
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
100000
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
7029000
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
7029000
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
7029000
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
7029000
CY2019 gdrx Debt Issuance Costs And Discounts
DebtIssuanceCostsAndDiscounts
600000
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3000000
CY2019 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3300000
CY2018 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
800000
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
653010000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
681126000
CY2018Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
40000000
CY2019 gdrx Line Of Credit Facility Extended Period
LineOfCreditFacilityExtendedPeriod
P1Y
CY2019 us-gaap Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
2024-10-11
CY2020 gdrx Line Of Credit Facility Fixed Fronting Fee Percentage
LineOfCreditFacilityFixedFrontingFeePercentage
0.00125
CY2020Q4 us-gaap Line Of Credit
LineOfCredit
0
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
0
CY2019Q4 gdrx Decrease Of Letter Of Credit
DecreaseOfLetterOfCredit
900000
CY2020Q2 us-gaap Line Of Credit Facility Increase Decrease For Period Net
LineOfCreditFacilityIncreaseDecreaseForPeriodNet
60000000
CY2020 us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.10
CY2018Q2 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
18600000
CY2018Q4 us-gaap Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
6400000
CY2020Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
5.94
CY2020Q4 gdrx Stock Issued During Period Value Charitable Stock Donation
StockIssuedDuringPeriodValueCharitableStockDonation
41700000
CY2020Q4 gdrx Percentage Of Discount Rate
PercentageOfDiscountRate
0.130
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.23
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.27
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.17
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
112700000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
11100000
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
11200000
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
10200000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2500000
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1600000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.004
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.014
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.027
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.014
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.024
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.029
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.50
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.60
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.50
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.62
CY2018 gdrx Payment Of Cash Bonus To Vested Option Holders
PaymentOfCashBonusToVestedOptionHolders
38800000
CY2018 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
12984000
CY2019 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
23607000
CY2018 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
17014000
CY2019 gdrx Undistributed Earnings Loss Reallocated To Common Shareholders Diluted
UndistributedEarningsLossReallocatedToCommonShareholdersDiluted
304000
CY2018 gdrx Undistributed Earnings Loss Reallocated To Common Shareholders Diluted
UndistributedEarningsLossReallocatedToCommonShareholdersDiluted
431000
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4602000
CY2018 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6502000
CY2020 gdrx Dividends Received From Subsidiary
DividendsReceivedFromSubsidiary
0
CY2019 gdrx Dividends Received From Subsidiary
DividendsReceivedFromSubsidiary
0
CY2018 gdrx Dividends Received From Subsidiary
DividendsReceivedFromSubsidiary
606000000

Files In Submission

Name View Source Status
0001564590-21-012614-index-headers.html Edgar Link pending
0001564590-21-012614-index.html Edgar Link pending
0001564590-21-012614.txt Edgar Link pending
0001564590-21-012614-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gci5mujrr20p000001.jpg Edgar Link pending
gci5mujrr20p000002.jpg Edgar Link pending
gci5mujrr20p000003.jpg Edgar Link pending
gci5mujrr20p000004.jpg Edgar Link pending
gci5mujrr20p000005.jpg Edgar Link pending
gci5mujrr20p000006.jpg Edgar Link pending
gci5mujrr20p000007.jpg Edgar Link pending
gci5mujrr20p000008.jpg Edgar Link pending
gci5mujrr20p000009.jpg Edgar Link pending
gci5mujrr20p000010.jpg Edgar Link pending
gdrx-10k_20201231.htm Edgar Link pending
gdrx-20201231.xml Edgar Link completed
gdrx-20201231.xsd Edgar Link pending
gdrx-20201231_cal.xml Edgar Link unprocessable
gdrx-20201231_def.xml Edgar Link unprocessable
gdrx-20201231_lab.xml Edgar Link unprocessable
gdrx-20201231_pre.xml Edgar Link unprocessable
gdrx-ex1010_463.htm Edgar Link pending
gdrx-ex1011_466.htm Edgar Link pending
gdrx-ex211_863.htm Edgar Link pending
gdrx-ex231_443.htm Edgar Link pending
gdrx-ex311_6.htm Edgar Link pending
gdrx-ex312_7.htm Edgar Link pending
gdrx-ex313_861.htm Edgar Link pending
gdrx-ex321_8.htm Edgar Link pending
gdrx-ex322_9.htm Edgar Link pending
gdrx-ex323_862.htm Edgar Link pending
gdrx-ex43_946.htm Edgar Link pending
genoahitb1na000001.jpg Edgar Link pending
genoahitb1na000002.jpg Edgar Link pending
genoahitb1na000003.jpg Edgar Link pending
genoahitb1na000004.jpg Edgar Link pending
genoahitb1na000005.jpg Edgar Link pending
genoahitb1na000006.jpg Edgar Link pending
genoahitb1na000007.jpg Edgar Link pending
genoahitb1na000008.jpg Edgar Link pending
genoahitb1na000009.jpg Edgar Link pending
genoahitb1na000010.jpg Edgar Link pending
genoahitb1na000011.jpg Edgar Link pending
genoahitb1na000012.jpg Edgar Link pending
genoahitb1na000013.jpg Edgar Link pending
genoahitb1na000014.jpg Edgar Link pending
genoahitb1na000015.jpg Edgar Link pending
genoahitb1na000016.jpg Edgar Link pending
genoahitb1na000017.jpg Edgar Link pending
ghutz0germhm000001.jpg Edgar Link pending
ghutz0germhm000002.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending